Literature DB >> 27249702

Lung Cancer Screening, Cancer Treatment, and Addressing the Continuum of Health Risks Caused by Tobacco.

Graham W Warren1, Jamie S Ostroff1, John R Goffin1.   

Abstract

Tobacco use is the largest preventable risk factor for the development of several cancers, and continued tobacco use by patients with cancer and survivors of cancer causes adverse outcomes. Worldwide tobacco control efforts have reduced tobacco use and improved health outcomes in many countries, but several countries continue to suffer from increased tobacco use and associated adverse health effects. Continued tobacco use by patients undergoing cancer screening or treatment results in continued risk for cancer-related and noncancer-related health conditions. Although integrating tobacco assessment and cessation support into lung cancer screening and cancer care is well justified and feasible, most patients with cancer unfortunately do not receive evidence-based tobacco cessation support. Combining evidence-based methods of treating tobacco addiction, such as behavioral counseling and pharmacotherapy, with practical clinical considerations in the setting of lung cancer screening and cancer treatment should result in substantial improvements in access to evidence-based care and resultant improvements in health risks and cancer treatment outcomes.

Entities:  

Mesh:

Year:  2016        PMID: 27249702     DOI: 10.1200/EDBK_158704

Source DB:  PubMed          Journal:  Am Soc Clin Oncol Educ Book        ISSN: 1548-8748


  2 in total

1.  Long-term follow-up of smokers following lung and colorectal cancer diagnosis.

Authors:  Elyse R Park; Sarah E Skurla; Grelda Yazmin Juarez Caballero; Emily R Friedman; Colin Ponzani; Robert Wallace; Jennifer Malin; Nancy L Keating
Journal:  Support Care Cancer       Date:  2022-05-12       Impact factor: 3.359

2.  Implementation of an Integrated Lung Cancer Prevention and Screening Program Using a Mobile Computed Tomography (CT) Unit in Brazil.

Authors:  Rodrigo Sampaio Chiarantano; Fabiana Lima Vazquez; Alexander Franco; Larissa Cristina Ferreira; Maraísa Cristina da Costa; Thais Talarico; Ângela Neves Oliveira; José Elias Miziara; Edmundo Carvalho Mauad; Eduardo Caetano da Silva; Luis Marcelo Ventura; Raphael Haikel Junior; Letícia Ferro Leal; Rui Manuel Reis
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 2.339

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.